ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

VIGL Vigil Neuroscience Inc

3.03
0.29 (10.58%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Vigil Neuroscience Inc VIGL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.29 10.58% 3.03 05:46:47
개장가 저가 고가 종가 전일 종가
2.72 2.67 3.05 3.03 2.74
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
18/04/202405:05GLOBEVigil Presents Key Findings from ILLUMINATE & IGNITE Studies..
26/03/202420:05GLOBEVigil Neuroscience Reports Fourth Quarter and Full Year 2023..
20/03/202420:05GLOBEVigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief..
13/03/202420:05GLOBEVigil Announces Upcoming Presentations at 2024 American..
12/03/202420:05GLOBEVigil Neuroscience to Present at Stifel 2024 Virtual CNS..
07/03/202406:25GLOBEVigil Announces Oral Presentation on Small Molecule TREM2..
02/03/202408:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:05GLOBEVigil Presents Poster on Impacts of Misdiagnosis and Genetic..
15/02/202401:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202406:05GLOBEVigil Neuroscience to Present at Guggenheim 6th Annual..
12/01/202400:30EDGAR2Form 8-K - Current report
04/01/202406:30GLOBEVigil Neuroscience Provides 2023 Year-in-Review and..
23/11/202306:05GLOBEVigil Neuroscience to Present at Evercore ISI 6th Annual..
17/11/202306:31EDGAR2Form 8-K - Current report
17/11/202306:05GLOBEVigil Neuroscience Reports Positive Interim Data from Phase..
07/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:15EDGAR2Form 8-K - Current report
07/11/202321:05GLOBEVigil Neuroscience Reports Third Quarter 2023 Financial..
17/10/202320:05GLOBEVigil Neuroscience Announces First Participant Dosed in..
13/10/202305:06EDGAR2Form 8-K - Current report
06/10/202305:01GLOBEVigil Neuroscience to Present at Jefferies Inaugural Biotech..
26/09/202320:05GLOBEVigil Neuroscience Receives Positive Opinion from European..
13/09/202320:31EDGAR2Form 8-K - Current report
12/09/202301:00GLOBEVigil Neuroscience Presents VGL101 Complete Phase 1 Data and..
09/09/202305:10EDGAR2Form 8-K - Current report
09/09/202305:05GLOBEVigil Neuroscience Announces Update on its Small Molecule..
08/09/202320:05GLOBEVigil Neuroscience to Present at 2023 Morgan Stanley Global..
08/08/202320:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:19EDGAR2Form 8-K - Current report
08/08/202320:05GLOBEVigil Neuroscience Reports Second Quarter 2023 Financial..
08/08/202307:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202307:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/08/202305:05GLOBEVigil Neuroscience Appoints Christopher J. Silber, M.D. as..
01/06/202320:00GLOBEVigil Neuroscience to Present at 2023 Jefferies Global..
10/05/202320:00GLOBEVigil Neuroscience Reports First Quarter 2023 Financial..
09/05/202320:00GLOBEVigil Neuroscience Appoints Samantha Budd Haeberlein, Ph.D...
08/05/202320:08GLOBEVigil Neuroscience Launches ALSPAware to Provide Access to..

최근 히스토리

Delayed Upgrade Clock